Risk of thrombogenicity among nonionic radiocontrast agents

Several contrast agents have been approved in the United States for radiographic imaging purposes. Most of the older ionic, high-osmolar contrast agents are no longer used because of their side effect profile. Therefore, newer nonionic, low or iso-osmolar contrast agents have been widely accepted as...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of invasive cardiology 2008-07, Vol.20 (7), p.349
Hauptverfasser:	Georgakis, Alexander, Ener, Rasih Atilla, Jin, Jianguo, Kunapuli, Satya, Fiss, David, Leech, Stephen H, Wolf, Nelson M, Van Decker, William A
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Platelets - drug effects Cardiac Catheterization - methods Contrast Media - adverse effects Contrast Media - pharmacology Coronary Thrombosis - chemically induced Coronary Thrombosis - epidemiology Coronary Thrombosis - physiopathology Dose-Response Relationship, Drug Humans Iohexol - adverse effects Iohexol - analogs & derivatives Iohexol - pharmacology Iopamidol - adverse effects Iopamidol - pharmacology Platelet Aggregation - drug effects Risk Factors Triiodobenzoic Acids - adverse effects Triiodobenzoic Acids - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!